BDBM72350 Step A: 9-chloro-2,8-difluoro-15,19-dioxo-10,11,12,13,14,15-hexahydro-19H-5,18-methanodibenzo[c,f]pyrido[3,2-j][1,5,9]triazacyclotridecine-3-carbonitrile::US20250368647, Example 67

SMILES N#Cc1cc2c(cc1F)C(=O)N1CN2c2ccc(F)c(Cl)c2CNCCc2[nH]c(=O)ccc21

InChI Key InChIKey=JMTYOGKXLZBBGH-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72350   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72350BDBM72350(Step A: 9-chloro-2,8-difluoro-15,19-dioxo-10,11,12...)
Affinity DataIC50: 5.01nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
PCBioAssay